CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced CEO Frank Reynolds will present InVivo’s most recent breakthroughs and provide a business update to potential investors at BOCEMb Noble Financial Capital Markets’ Eight Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, on Wednesday, January 18th at 9:00 am EST.
